patent applications filed for manufacturing processes patent-pending technology aims to improve yields and ultimately margins Calgary, Alberta–(Newsfile Corp. – October 6, 2021) – Psygen Industries Ltd. (“ Psygen” or the “Company“) provided an update today on use of psilocybin in humans and on its intellectual property portfolio. Psygen is excited to announce that psilocybin recently used in a…


Previous articleMydecine Completes Spin-Out of U.S. Cannabis Assets
Next articlePsyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1